What is the ticker symbol for Atossa Therapeutics?

Atossa Therapeutics trades under the ticker ATOS on NASDAQ.

What sector does Atossa Therapeutics operate in?

Atossa Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ATOS in a portfolio?

PortView shows ATOS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Atossa Therapeutics (ATOS) Stock Analysis

NASDAQHealthcareBiotechnology

$2.38-1.65%

1-year price historyRange $1.75 – $17.70

52-week range$2.38

$1.70$19.35

What Atossa Therapeutics does

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medicines. Their primary focus lies in addressing unmet medical needs in women's oncology, especially breast cancer, along with other conditions, within the United States. The company's flagship therapeutic candidate is oral (Z)-endoxifen. This compound, an active metabolite derived from tamoxifen, is currently undergoing Phase II clinical trials for both the treatment and prevention of breast cancer. Beyond this, Atossa is also advancing immunotherapy and chimeric antigen receptor (CAR) therapy programs. Established in 2008, the company adopted its current name, Atossa Therapeutics, Inc., in January 2020, having previously operated as Atossa Genetics Inc. It is headquartered in Seattle, Washington.

Key metrics

Market cap

$23.74M

P/E (TTM)

-0.55

EPS (TTM)

$-4.30

Beta

1.25

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$2.36

200-day avg

$5.73

52-week high

$19.35

52-week low

$1.70

CEO

Steven C. Quay

ETFs linked to ATOS

Broad-market and Healthcare sector ETFs an investor holding Atossa Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ATOS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ATOS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Atossa Therapeutics?: Atossa Therapeutics trades under the ticker ATOS on NASDAQ.
Which exchange is ATOS listed on?: ATOS is listed on NASDAQ.
What sector does Atossa Therapeutics operate in?: Atossa Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ATOS in a portfolio?: PortView shows ATOS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.